NASDAQ:AVIR

Atea Pharmaceuticals News Headlines

$7.29

+0.86 (+13.37%)

(As of 05/13/2022 06:55 PM ET)

Add

Compare

Today's Range: $6.47
▼
$7.36
50-Day Range: $5.33
▼
$7.33
52-Week Range: $5.31
▼
$46.91

Volume: 1.20 million shs
Average Volume: 939,612 shs
Market Capitalization: $606.95 million

P/E Ratio: 14.29
Dividend Yield: N/A
Beta: -0.58

Get Atea Pharmaceuticals News Delivered to You Automatically

Media Mentions By Week

Atea Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVIR
News Sentiment
▼
0.07

0.48
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVIR Articles
This Week
▼
19

1
▲
AVIR Articles
Average Week

Atea Pharmaceuticals (NASDAQ:AVIR) News Headlines Today

Source

Source	Headline
	FY2022 EPS Estimates for Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Lowered by Analyst marketbeat.com - May 13 at 9:47 AM
	Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Forecasted to Earn Q2 2022 Earnings of ($0.52) Per Share americanbankingnews.com - May 15 at 1:58 AM
	SVB Leerink Equities Analysts Lower Earnings Estimates for Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) americanbankingnews.com - May 14 at 3:56 AM
	Atea Pharmaceuticals (NASDAQ:AVIR) Trading 9% Higher After Better-Than-Expected Earnings americanbankingnews.com - May 12 at 1:52 AM
	A Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) insider increased their holdings by 106% last year finance.yahoo.com - May 11 at 11:33 AM
	Atea Pharmaceuticals, Inc. (AVIR) Q1 2022 Earnings Call Transcript fool.com - May 10 at 7:27 PM
	Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q1 2022 Results - Earnings Call Transcript seekingalpha.com - May 10 at 5:57 PM
	Atea Pharmaceuticals: Q1 Earnings Insights benzinga.com - May 10 at 12:56 PM
	Atea Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation seekingalpha.com - May 10 at 10:23 AM
	Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com - May 10 at 7:47 AM
	Atea Pharmaceuticals (AVIR) to Release Earnings on Tuesday americanbankingnews.com - May 9 at 5:18 AM

	Atea Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call on May 10, 2022 finance.yahoo.com - May 3 at 5:51 PM
	What Kind Of Investors Own Most Of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)? finance.yahoo.com - March 30 at 1:23 PM
	Atea Pharmaceuticals, Inc. (AVIR) Surges 7.4%: Is This an Indication of Further Gains? finance.yahoo.com - March 21 at 11:54 AM
	Atea Pharmaceuticals Earnings Perspective: Return On Invested Capital benzinga.com - March 2 at 1:04 PM
	Thinking about buying stock in CTI BioPharma, 3D Systems, Atea Pharmaceuticals, Editas Medicine, or Mullen Automotive? morningstar.com - March 1 at 5:00 PM
	Atea Pharma stock jumps as earnings rise, potential COVID-19 therapy advances msn.com - March 1 at 1:40 AM
	Atea Pharmaceuticals, Inc. (AVIR) Q4 2021 Earnings Call Transcript fool.com - February 28 at 11:16 PM
	Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update finance.yahoo.com - February 28 at 8:40 PM
	Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 28, 2022 finance.yahoo.com - February 22 at 7:16 PM
	8 Biotech Stocks So Cheap That Their Technology Is Effectively Free finance.yahoo.com - February 16 at 2:19 PM
	Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes finance.yahoo.com - February 11 at 10:09 AM
	Atea Pharmaceuticals Appoints Nancy Gail Berry Agrawal, Ph.D., as Executive Vice President of Preclinical Development finance.yahoo.com - February 10 at 2:07 PM
	Atea Pharmaceuticals to Present at 11th Annual SVB Leerink Global Healthcare Conference finance.yahoo.com - February 9 at 9:58 AM
	Atea Pharmaceuticals Announces Publication of Data Supporting Bemnifosbuvir’s (AT-527) Novel Mechanism of Action Against SARS-CoV-2 in Nature Communications finance.yahoo.com - February 2 at 8:13 AM
	With A 4.3% Return On Equity, Is Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) A Quality Stock? finance.yahoo.com - January 28 at 9:14 AM
	Atea Pharmaceuticals Inc Ordinary Shares AVIR morningstar.com - January 25 at 7:14 PM
	Atea Pharmaceuticals, Inc. Common Stock (AVIR) nasdaq.com - January 25 at 7:14 PM
	Atea Pharma highlights strategic priorities for 2022 seekingalpha.com - January 7 at 9:19 AM
	Atea Pharmaceuticals Highlights Strategic Priorities for 2022 finance.yahoo.com - January 7 at 9:19 AM
	Atea cut to Underweight at Morgan Stanley citing concerns over oral COVID-19 drug seekingalpha.com - January 6 at 6:00 PM
	Atea Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 3 at 8:34 AM
	Atea Pharmaceuticals Added to the Nasdaq Biotechnology Index finance.yahoo.com - December 17 at 8:59 AM

	After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial markets.businessinsider.com - December 15 at 8:27 AM
	Atea Pharmaceuticals Introduces New Strategic Clinical Development Program for AT-527 in COVID-19 finance.yahoo.com - December 14 at 8:09 PM
	Hedge Funds Are Piling Into Atea Pharmaceuticals, Inc. (AVIR) finance.yahoo.com - December 12 at 2:33 PM
	Implied Volatility Surging for Atea (AVIR) Stock Options finance.yahoo.com - December 1 at 3:09 PM
	Atea Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference finance.yahoo.com - November 22 at 9:38 AM
	What 5 Analyst Ratings Have To Say About Atea Pharmaceuticals markets.businessinsider.com - November 18 at 3:15 PM
	Atea (AVIR) Plunges on Termination of Collaboration With Roche finance.yahoo.com - November 17 at 1:13 PM
	Atea Pharma says deal to develop COVID-19 pill with Roche terminated reuters.com - November 16 at 7:44 PM
	Atea Pharmaceuticals Provides Update on Strategic Collaboration with Roche finance.yahoo.com - November 16 at 7:44 PM
	UPDATE 1-Roche terminates partnership with Atea to develop COVID-19 pill finance.yahoo.com - November 16 at 7:44 PM
	Atea Pharma Stock Collapses As Roche Pulls The Plug On Pfizer-Rivaling Covid Pill finance.yahoo.com - November 16 at 7:44 PM
	Atea Pharmaceuticals Inc (AVIR) Q3 2021 Earnings Call Transcript finance.yahoo.com - November 12 at 9:34 AM
	Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2021 Financial Results finance.yahoo.com - November 11 at 7:15 PM
	Is There Any Hope for Atea Pharmaceuticals Stock? finance.yahoo.com - November 4 at 8:52 AM
	Atea Pharmaceuticals to Host Third Quarter Financial Results Conference Call on November 11, 2021 finance.yahoo.com - November 4 at 8:52 AM
	Investors one-year losses grow to 62% as the stock sheds US$90m this past week finance.yahoo.com - October 30 at 1:54 PM
	Why Atea Pharmaceuticals Stock Got Crushed This Week finance.yahoo.com - October 22 at 7:56 PM
	J.P. Morgan’s Bullish Stance on Atea Pharmaceuticals Stock Comes to an End finance.yahoo.com - October 21 at 1:26 AM

Get Atea Pharmaceuticals News Delivered to You Automatically

This page was last updated on 5/16/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources